Logo image of CHMG

CHEMUNG FINANCIAL CORP (CHMG) Stock Fundamental Analysis

NASDAQ:CHMG - Nasdaq - US1640241014 - Common Stock - Currency: USD

49.25  -0.5 (-1.01%)

After market: 49.25 0 (0%)

Fundamental Rating

5

Taking everything into account, CHMG scores 5 out of 10 in our fundamental rating. CHMG was compared to 392 industry peers in the Banks industry. CHMG has an average financial health and profitability rating. CHMG may be a bit undervalued, certainly considering the very reasonable score on growth


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

CHMG had positive earnings in the past year.
In the past year CHMG had a positive cash flow from operations.
In the past 5 years CHMG has always been profitable.
CHMG had a positive operating cash flow in each of the past 5 years.
CHMG Yearly Net Income VS EBIT VS OCF VS FCFCHMG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

1.2 Ratios

CHMG has a Return On Assets (0.81%) which is in line with its industry peers.
The Return On Equity of CHMG (9.89%) is better than 65.82% of its industry peers.
Industry RankSector Rank
ROA 0.81%
ROE 9.89%
ROIC N/A
ROA(3y)0.95%
ROA(5y)0.96%
ROE(3y)13.7%
ROE(5y)12.65%
ROIC(3y)N/A
ROIC(5y)N/A
CHMG Yearly ROA, ROE, ROICCHMG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

The Profit Margin of CHMG (22.74%) is comparable to the rest of the industry.
In the last couple of years the Profit Margin of CHMG has grown nicely.
The Operating Margin and Gross Margin are not available for CHMG so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 22.74%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-6.27%
PM growth 5Y4.69%
GM growth 3YN/A
GM growth 5YN/A
CHMG Yearly Profit, Operating, Gross MarginsCHMG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

More info and screens

4

2. Health

2.1 Basic Checks

CHMG does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CHMG has more shares outstanding
CHMG has less shares outstanding than it did 5 years ago.
CHMG has a worse debt/assets ratio than last year.
CHMG Yearly Shares OutstandingCHMG Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M
CHMG Yearly Total Debt VS Total AssetsCHMG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

The Debt to FCF ratio of CHMG is 0.15, which is an excellent value as it means it would take CHMG, only 0.15 years of fcf income to pay off all of its debts.
CHMG has a better Debt to FCF ratio (0.15) than 87.76% of its industry peers.
A Debt/Equity ratio of 0.02 indicates that CHMG is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.02, CHMG belongs to the top of the industry, outperforming 86.22% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.15
Altman-Z N/A
ROIC/WACCN/A
WACC20.23%
CHMG Yearly LT Debt VS Equity VS FCFCHMG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
CHMG Yearly Current Assets VS Current LiabilitesCHMG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

5

3. Growth

3.1 Past

CHMG shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 1.01%.
The Earnings Per Share has been growing by 9.09% on average over the past years. This is quite good.
Looking at the last year, CHMG shows a decrease in Revenue. The Revenue has decreased by -1.73% in the last year.
CHMG shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.81% yearly.
EPS 1Y (TTM)1.01%
EPS 3Y-4.19%
EPS 5Y9.09%
EPS Q2Q%24.76%
Revenue 1Y (TTM)-1.73%
Revenue growth 3Y2.84%
Revenue growth 5Y3.81%
Sales Q2Q%-56.75%

3.2 Future

Based on estimates for the next years, CHMG will show a quite strong growth in Earnings Per Share. The EPS will grow by 19.08% on average per year.
The Revenue is expected to grow by 10.98% on average over the next years. This is quite good.
EPS Next Y16.54%
EPS Next 2Y19.08%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year11.47%
Revenue Next 2Y10.98%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CHMG Yearly Revenue VS EstimatesCHMG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M 100M
CHMG Yearly EPS VS EstimatesCHMG Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2 4 6

More info and screens

7

4. Valuation

4.1 Price/Earnings Ratio

CHMG is valuated reasonably with a Price/Earnings ratio of 9.85.
Compared to the rest of the industry, the Price/Earnings ratio of CHMG indicates a somewhat cheap valuation: CHMG is cheaper than 77.04% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 26.54. CHMG is valued rather cheaply when compared to this.
A Price/Forward Earnings ratio of 7.00 indicates a rather cheap valuation of CHMG.
88.78% of the companies in the same industry are more expensive than CHMG, based on the Price/Forward Earnings ratio.
CHMG's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 35.28.
Industry RankSector Rank
PE 9.85
Fwd PE 7
CHMG Price Earnings VS Forward Price EarningsCHMG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, CHMG is valued a bit cheaper than the industry average as 64.03% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 9.4
EV/EBITDA N/A
CHMG Per share dataCHMG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CHMG's earnings are expected to grow with 19.08% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.6
PEG (5Y)1.08
EPS Next 2Y19.08%
EPS Next 3YN/A

More info and screens

6

5. Dividend

5.1 Amount

CHMG has a Yearly Dividend Yield of 2.53%. Purely for dividend investing, there may be better candidates out there.
CHMG's Dividend Yield is slightly below the industry average, which is at 3.51.
CHMG's Dividend Yield is comparable with the S&P500 average which is at 2.40.
Industry RankSector Rank
Dividend Yield 2.53%

5.2 History

The dividend of CHMG is nicely growing with an annual growth rate of 8.39%!
CHMG has paid a dividend for at least 10 years, which is a reliable track record.
CHMG has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)8.39%
Div Incr Years0
Div Non Decr Years14
CHMG Yearly Dividends per shareCHMG Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

32.91% of the earnings are spent on dividend by CHMG. This is a low number and sustainable payout ratio.
The dividend of CHMG is growing, but earnings are growing more, so the dividend growth is sustainable.
DP32.91%
EPS Next 2Y19.08%
EPS Next 3YN/A
CHMG Yearly Income VS Free CF VS DividendCHMG Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
CHMG Dividend Payout.CHMG Dividend Payout, showing the Payout Ratio.CHMG Dividend Payout.PayoutRetained Earnings

More info and screens

CHEMUNG FINANCIAL CORP

NASDAQ:CHMG (8/7/2025, 8:16:55 PM)

After market: 49.25 0 (0%)

49.25

-0.5 (-1.01%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)07-17 2025-07-17/amc
Earnings (Next)10-20 2025-10-20/amc
Inst Owners44.23%
Inst Owner Change-0.17%
Ins Owners6.97%
Ins Owner Change5.64%
Market Cap236.89M
Analysts80
Price Target56.61 (14.94%)
Short Float %0.93%
Short Ratio2.83
Dividend
Industry RankSector Rank
Dividend Yield 2.53%
Yearly Dividend1.55
Dividend Growth(5Y)8.39%
DP32.91%
Div Incr Years0
Div Non Decr Years14
Ex-Date06-17 2025-06-17 (0.32)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)2.02%
Min EPS beat(2)0.8%
Max EPS beat(2)3.23%
EPS beat(4)3
Avg EPS beat(4)-0.05%
Min EPS beat(4)-7.92%
Max EPS beat(4)3.7%
EPS beat(8)6
Avg EPS beat(8)7.11%
EPS beat(12)9
Avg EPS beat(12)9.4%
EPS beat(16)13
Avg EPS beat(16)11.66%
Revenue beat(2)1
Avg Revenue beat(2)-0.54%
Min Revenue beat(2)-2.69%
Max Revenue beat(2)1.62%
Revenue beat(4)1
Avg Revenue beat(4)-2%
Min Revenue beat(4)-4.88%
Max Revenue beat(4)1.62%
Revenue beat(8)3
Avg Revenue beat(8)-1.09%
Revenue beat(12)4
Avg Revenue beat(12)-0.47%
Revenue beat(16)7
Avg Revenue beat(16)-0.24%
PT rev (1m)3.42%
PT rev (3m)4.72%
EPS NQ rev (1m)-1.54%
EPS NQ rev (3m)0.36%
EPS NY rev (1m)0.87%
EPS NY rev (3m)5.96%
Revenue NQ rev (1m)-0.04%
Revenue NQ rev (3m)-1.1%
Revenue NY rev (1m)0.47%
Revenue NY rev (3m)0.27%
Valuation
Industry RankSector Rank
PE 9.85
Fwd PE 7
P/S 2.39
P/FCF 9.4
P/OCF 8.15
P/B 1.04
P/tB 1.15
EV/EBITDA N/A
EPS(TTM)5
EY10.15%
EPS(NY)7.03
Fwd EY14.28%
FCF(TTM)5.24
FCFY10.63%
OCF(TTM)6.04
OCFY12.27%
SpS20.63
BVpS47.46
TBVpS42.93
PEG (NY)0.6
PEG (5Y)1.08
Profitability
Industry RankSector Rank
ROA 0.81%
ROE 9.89%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 22.74%
GM N/A
FCFM 25.38%
ROA(3y)0.95%
ROA(5y)0.96%
ROE(3y)13.7%
ROE(5y)12.65%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-6.27%
PM growth 5Y4.69%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.15
Debt/EBITDA N/A
Cap/Depr 213.27%
Cap/Sales 3.9%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 111.58%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score5
WACC20.23%
ROIC/WACCN/A
Cap/Depr(3y)80.7%
Cap/Depr(5y)56.24%
Cap/Sales(3y)1.55%
Cap/Sales(5y)1.22%
Profit Quality(3y)117.54%
Profit Quality(5y)125.93%
High Growth Momentum
Growth
EPS 1Y (TTM)1.01%
EPS 3Y-4.19%
EPS 5Y9.09%
EPS Q2Q%24.76%
EPS Next Y16.54%
EPS Next 2Y19.08%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-1.73%
Revenue growth 3Y2.84%
Revenue growth 5Y3.81%
Sales Q2Q%-56.75%
Revenue Next Year11.47%
Revenue Next 2Y10.98%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-35.51%
FCF growth 3Y-9.29%
FCF growth 5Y0.51%
OCF growth 1Y-26.91%
OCF growth 3Y-5.62%
OCF growth 5Y2.46%